HPGD and colitis: Zhang et al. 40 discovered that inhibiting 15-hydroxyprostaglandin dehydrogenase, an enzyme that physiologically oxidizes PGE2 to prevent it from binding to prostaglandin receptors, led to improvements in hematopoietic stem cell transplants and colitis recovery during injury.